Open AccessAssociation of adiponectin with lung function impairment and disease severity in chronic obstructive pulmonary disease
Author(s) -
Shivani Jaswal,
Varinder Saini,
Jasbinder Kaur,
Seema Gupta,
Harjeet Kaur,
Kranti Garg
Publication year - 2018
Publication title -
international journal of applied and basic medical research/international journal of applied and basic medical research
Language(s) - English
Resource type - Journals
eISSN - 2248-9606
pISSN - 2229-516X
DOI - 10.4103/ijabmr.ijabmr_65_17
Subject(s) - copd , medicine , pulmonary function testing , exacerbation , adiponectin , biomarker , systemic inflammation , pathogenesis , inflammation , pulmonary disease , gastroenterology , obesity , insulin resistance , biochemistry , chemistry
Chronic obstructive pulmonary disease (COPD) is not only restricted to the pulmonary inflammation and airway obstruction but is also associated with comorbidities, which affect the therapeutic intervention and the quality of life and survival. Markers that can predict the systemic inflammation and a decline in the pulmonary function are of scientific interest. Adiponectin (APN) appears to be one such biomarker and can be used as a potential indicator of severity and response to treatment in patients of COPD.